Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-22-027660
Date:2022-05-05
Issuer: NURIX THERAPEUTICS, INC. (NRIX)
Original Submission Date:

Reporting Person:

GREGORY JULIA P
C/O NURIX THERAPEUTICS, INC.
1700 OWENS STREET, SUITE 205 SAN FRANCISCO, CA 94158

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
DIRECTOR STOCK OPTION (RIGHT TO BUY) 10.39 2022-05-05 deemed execution date A 17,500 (a) 2032-05-04 common stock 17,500 $10.39 17,500 direct
Footnotes
IDfootnote
f1 the stock option vests as to 100% of the award on the earlier of (a) the date of the next annual meeting of the issuer's stockholders and (b) may 6, 2023, in each case, subject to the reporting person's provision of service to the issuer on such vesting date.

Elevate your investments